Furthermore, we demonstrated that activating Piezo1 can profoundly improve mLV function in facilitating CSF outflow and subsequently applied this innovative concept to two neurological disease models, identifying the potential therapeutic benefits of Piezo1 activation in alleviating excessive CSF accumulation observed in hydrocephalus and ventriculomegaly. The gene discussed is PIEZO1; the disease is Hydrocephalus.